{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T14:46:00Z","timestamp":1782398760030,"version":"3.54.5"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,25]]},"DOI":"10.7759\/cureus.111479","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T13:46:31Z","timestamp":1782395191000},"source":"Crossref","is-referenced-by-count":0,"title":["Masked Nocturnal Hypertension and Hidden Organ Risk: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Anas M","family":"Berro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa M","family":"Obeid Alla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Madani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayan E","family":"Elkhair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eithar","family":"Musa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morad Mohammad","family":"Ahourani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asim","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants","volume":"398","year":"2021","unstructured":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019. a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021, 398:957-80. 10.1016\/S0140-6736(21)01330-1","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC Guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy JW","year":"2024","unstructured":"McEvoy JW, McCarthy CP, Bruno RM, et al.. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024, 45:3912-4018. 10.1093\/eurheartj\/ehae178","journal-title":"Eur Heart J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)","volume":"41","author":"Mancia G","year":"2023","unstructured":"Mancia G, Kreutz R, Brunstr\u00f6m M, et al.. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023, 41:1874-2071. 10.1097\/HJH.0000000000003480","journal-title":"J Hypertens"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002843","article-title":"2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement","volume":"39","author":"Stergiou GS","year":"2021","unstructured":"Stergiou GS, Palatini P, Parati G, et al.. 2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement. J Hypertens. 2021, 39:1293-302. 10.1097\/HJH.0000000000002843","journal-title":"J Hypertens"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000000221","article-title":"European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring","volume":"32","author":"Parati G","year":"2014","unstructured":"Parati G, Stergiou G, O'Brien E, et al.. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens. 2014, 32:1359-66. 10.1097\/HJH.0000000000000221","journal-title":"J Hypertens"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.04522","article-title":"Masked hypertension: a phenomenon of measurement","volume":"65","author":"Franklin SS","year":"2015","unstructured":"Franklin SS, O'Brien E, Thijs L, Asayama K, Staessen JA. Masked hypertension: a phenomenon of measurement. Hypertension. 2015, 65:16-20. 10.1161\/HYPERTENSIONAHA.114.04522","journal-title":"Hypertension"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.10971","article-title":"Nocturnal hypertension: new technology and evidence","volume":"71","author":"Kario K","year":"2018","unstructured":"Kario K. Nocturnal hypertension: new technology and evidence. Hypertension. 2018, 71:997-1009. 10.1161\/HYPERTENSIONAHA.118.10971","journal-title":"Hypertension"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61538-4","article-title":"Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study","volume":"370","author":"Boggia J","year":"2007","unstructured":"Boggia J, Li Y, Thijs L, et al.. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet. 2007, 370:1219-29. 10.1016\/S0140-6736(07)61538-4","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.107.100727","article-title":"Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension","volume":"51","author":"Fagard RH","year":"2008","unstructured":"Fagard RH, Celis H, Thijs L, Staessen JA, Clement DL, De Buyzere ML, De Bacquer DA. Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension. 2008, 51:55-61. 10.1161\/HYPERTENSIONAHA.107.100727","journal-title":"Hypertension"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.109.133900","article-title":"Predictive role of the nighttime blood pressure","volume":"57","author":"Hansen TW","year":"2011","unstructured":"Hansen TW, Li Y, Boggia J, Thijs L, Richart T, Staessen JA. Predictive role of the nighttime blood pressure. Hypertension. 2011, 57:3-10. 10.1161\/HYPERTENSIONAHA.109.133900","journal-title":"Hypertension"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2015.43","article-title":"Isolated nocturnal hypertension and subclinical target organ damage: a systematic review of the literature","volume":"38","author":"O'Flynn AM","year":"2015","unstructured":"O'Flynn AM, Madden JM, Russell AJ, Curtin RJ, Kearney PM. Isolated nocturnal hypertension and subclinical target organ damage: a systematic review of the literature. Hypertens Res. 2015, 38:570-5. 10.1038\/hr.2015.43","journal-title":"Hypertens Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.11499","article-title":"Prognostic value of masked uncontrolled hypertension","volume":"72","author":"Pierdomenico SD","year":"2018","unstructured":"Pierdomenico SD, Pierdomenico AM, Coccina F, et al.. Prognostic value of masked uncontrolled hypertension. Hypertension. 2018, 72:862-9. 10.1161\/HYPERTENSIONAHA.118.11499","journal-title":"Hypertension"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref14","unstructured":"The Newcastle-Ottawa Scale for assessing the quality of nonrandomised studies in meta-analyses. Accessed. June 10, 2026: https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"ref15","unstructured":"Joanna Briggs Institute. critical appraisal tools. Accessed: June 10, 2026:  https:\/\/jbi.global\/critical-appraisal-tools."},{"key":"ref16","unstructured":"Cochrane Handbook for Systematic Reviews of Interventions (Version 6.5). ( 2024). Accessed. June 10, 2026: https:\/\/training.cochrane.org\/handbook."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-009-1369-9","article-title":"Masked nocturnal hypertension--a novel marker of risk in type 2 diabetes","volume":"52","author":"Wijkman M","year":"2009","unstructured":"Wijkman M, L\u00e4nne T, Engvall J, Lindstr\u00f6m T, Ostgren CJ, Nystrom FH. Masked nocturnal hypertension--a novel marker of risk in type 2 diabetes. Diabetologia. 2009, 52:1258-64. 10.1007\/s00125-009-1369-9","journal-title":"Diabetologia"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.14460","article-title":"Association of nighttime masked uncontrolled hypertension with left ventricular hypertrophy and kidney function among patients with chronic kidney disease not receiving dialysis","volume":"5","author":"Fu X","year":"2022","unstructured":"Fu X, Ren H, Xie J, Wang W, Li Y, Gao P, Chen N. Association of nighttime masked uncontrolled hypertension with left ventricular hypertrophy and kidney function among patients with chronic kidney disease not receiving dialysis. JAMA Netw Open. 2022, 5:e2214460. 10.1001\/jamanetworkopen.2022.14460","journal-title":"JAMA Netw Open"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-022-00899-6","article-title":"Masked nocturnal hypertension as a result of high prevalence of non-dippers among apparently well-controlled hypertensive patients with type 2 diabetes mellitus: data from a prospective study","volume":"14","author":"C\u0103lin P","year":"2022","unstructured":"C\u0103lin P, Viorel M, Luchiana P, Mihaela C, Lavinia P. Masked nocturnal hypertension as a result of high prevalence of non-dippers among apparently well-controlled hypertensive patients with type 2 diabetes mellitus: data from a prospective study. Diabetol Metab Syndr. 2022, 14:130. 10.1186\/s13098-022-00899-6","journal-title":"Diabetol Metab Syndr"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e32833b49fe","article-title":"Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations","volume":"28","author":"Fan HQ","year":"2010","unstructured":"Fan HQ, Li Y, Thijs L, et al.. Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J Hypertens. 2010, 28:2036-45. 10.1097\/HJH.0b013e32833b49fe","journal-title":"J Hypertens"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.004198","article-title":"Prognostic effect of isolated nocturnal hypertension in chinese patients with nondialysis chronic kidney disease","volume":"5","author":"Wang C","year":"2016","unstructured":"Wang C, Li Y, Zhang J, et al.. Prognostic effect of isolated nocturnal hypertension in chinese patients with nondialysis chronic kidney disease. J Am Heart Assoc. 2016, 5:10.1161\/JAHA.116.004198","journal-title":"J Am Heart Assoc"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/jch.13361","article-title":"Nocturnal blood pressure patterns and cardiovascular outcomes in patients with masked hypertension","volume":"20","author":"Presta V","year":"2018","unstructured":"Presta V, Figliuzzi I, D'Agostino M, et al.. Nocturnal blood pressure patterns and cardiovascular outcomes in patients with masked hypertension. J Clin Hypertens (Greenwich). 2018, 20:1238-46. 10.1111\/jch.13361","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/jch.14234","article-title":"Different effects of morning and nocturnal hypertension on target organ damage in chronic kidney disease","volume":"23","author":"Li X","year":"2021","unstructured":"Li X, Ke J, Chen X, et al.. Different effects of morning and nocturnal hypertension on target organ damage in chronic kidney disease. J Clin Hypertens (Greenwich). 2021, 23:1051-9. 10.1111\/jch.14234","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpu002","article-title":"Risk stratification by ambulatory blood pressure monitoring across JNC classes of conventional blood pressure","volume":"27","author":"Brguljan-Hitij J","year":"2014","unstructured":"Brguljan-Hitij J, Thijs L, Li Y, et al.. Risk stratification by ambulatory blood pressure monitoring across JNC classes of conventional blood pressure. Am J Hypertens. 2014, 27:956-65. 10.1093\/ajh\/hpu002","journal-title":"Am J Hypertens"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000003950","article-title":"Mortality risks in different subtypes of masked hypertension in the Spanish ambulatory blood pressure monitoring registry","volume":"43","author":"de la Sierra A","year":"2025","unstructured":"de la Sierra A, Ruilope LM, Staplin N, Stergiou GS, Williams B. Mortality risks in different subtypes of masked hypertension in the Spanish ambulatory blood pressure monitoring registry. J Hypertens. 2025, 43:642-8. 10.1097\/HJH.0000000000003950","journal-title":"J Hypertens"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/diseases13040107","article-title":"Relationships of isolated nocturnal hypertension with glomerular filtration rate and albuminuria","volume":"13","author":"Carollo C","year":"2025","unstructured":"Carollo C, Geraci G, Sorce A, et al.. Relationships of isolated nocturnal hypertension with glomerular filtration rate and albuminuria. Diseases. 2025, 13:10.3390\/diseases13040107","journal-title":"Diseases"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpt064","article-title":"Correlates of isolated nocturnal hypertension and target organ damage in a population-based cohort of African Americans: the Jackson Heart Study","volume":"26","author":"Ogedegbe G","year":"2013","unstructured":"Ogedegbe G, Spruill TM, Sarpong DF, et al.. Correlates of isolated nocturnal hypertension and target organ damage in a population-based cohort of African Americans: the Jackson Heart Study. Am J Hypertens. 2013, 26:1011-6. 10.1093\/ajh\/hpt064","journal-title":"Am J Hypertens"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.30.143","article-title":"Masked nocturnal hypertension and target organ damage in hypertensives with well-controlled self-measured home blood pressure","volume":"30","author":"Hoshide S","year":"2007","unstructured":"Hoshide S, Ishikawa J, Eguchi K, Ojima T, Shimada K, Kario K. Masked nocturnal hypertension and target organ damage in hypertensives with well-controlled self-measured home blood pressure. Hypertens Res. 2007, 30:143-9. 10.1291\/hypres.30.143","journal-title":"Hypertens Res"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.107.087767","article-title":"Is isolated nocturnal hypertension a novel clinical entity? Findings from a Chinese population study","volume":"50","author":"Li Y","year":"2007","unstructured":"Li Y, Staessen JA, Lu L, Li LH, Wang GL, Wang JG. Is isolated nocturnal hypertension a novel clinical entity? Findings from a Chinese population study. Hypertension. 2007, 50:333-9. 10.1161\/HYPERTENSIONAHA.107.087767","journal-title":"Hypertension"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200211000-00017","article-title":"Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study","volume":"20","author":"Ohkubo T","year":"2002","unstructured":"Ohkubo T, Hozawa A, Yamaguchi J, et al.. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens. 2002, 20:2183-9. 10.1097\/00004872-200211000-00017","journal-title":"J Hypertens"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.116.07553","article-title":"Masked hypertension and cardiovascular disease events in a prospective cohort of blacks: the Jackson Heart Study","volume":"68","author":"Booth JN 3rd","year":"2016","unstructured":"Booth JN 3rd, Diaz KM, Seals SR, Sims M, Ravenell J, Muntner P, Shimbo D. Masked hypertension and cardiovascular disease events in a prospective cohort of blacks: the Jackson Heart Study. Hypertension. 2016, 68:501-10. 10.1161\/HYPERTENSIONAHA.116.07553","journal-title":"Hypertension"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.08530815","article-title":"Masked hypertension and elevated nighttime blood pressure in CKD: prevalence and association with target organ damage","volume":"11","author":"Drawz PE","year":"2016","unstructured":"Drawz PE, Alper AB, Anderson AH, et al.. Masked hypertension and elevated nighttime blood pressure in CKD: prevalence and association with target organ damage. Clin J Am Soc Nephrol. 2016, 11:642-52. 10.2215\/CJN.08530815","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1080\/08037051.2020.1763159","article-title":"Subtypes of masked hypertension and target organ damage in untreated outpatients","volume":"29","author":"Zhang DY","year":"2020","unstructured":"Zhang DY, Cheng YB, Guo QH, et al.. Subtypes of masked hypertension and target organ damage in untreated outpatients. Blood Press. 2020, 29:299-307. 10.1080\/08037051.2020.1763159","journal-title":"Blood Press"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.025641","article-title":"Prevalence of isolated nocturnal hypertension and development of arterial stiffness, left ventricular hypertrophy, and silent cerebrovascular lesions: the KoGES (Korean Genome and Epidemiology Study)","volume":"11","author":"Kim SH","year":"2022","unstructured":"Kim SH, Shin C, Kim S, et al.. Prevalence of isolated nocturnal hypertension and development of arterial stiffness, left ventricular hypertrophy, and silent cerebrovascular lesions: the KoGES (Korean Genome and Epidemiology Study). J Am Heart Assoc. 2022, 11:e025641. 10.1161\/JAHA.122.025641","journal-title":"J Am Heart Assoc"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1111\/jch.13711","article-title":"Nocturnal systolic hypertension is a risk factor for cardiac damage in the untreated masked hypertensive patients","volume":"21","author":"Li J","year":"2019","unstructured":"Li J, Cao Y, Liu C, Li J, Yao F, Dong Y, Huang H. Nocturnal systolic hypertension is a risk factor for cardiac damage in the untreated masked hypertensive patients. J Clin Hypertens (Greenwich). 2019, 21:1666-74. 10.1111\/jch.13711","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002930","article-title":"Lower ambulatory nocturnal SBP is associated with less cardiovascular and renal damage in normotensive hospitalized patients with chronic kidney disease","volume":"39","author":"Zhang J","year":"2021","unstructured":"Zhang J, Song J, Zhou L, et al.. Lower ambulatory nocturnal SBP is associated with less cardiovascular and renal damage in normotensive hospitalized patients with chronic kidney disease. J Hypertens. 2021, 39:2241-9. 10.1097\/HJH.0000000000002930","journal-title":"J Hypertens"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.15419\/bmrat.v12i1.953","article-title":"Nocturnal high blood pressure and left ventricular hypertrophy in patients with chronic kidney disease","volume":"12","author":"Do TM","year":"2025","unstructured":"Do TM, Nguyen SV, Vo DT, Tran HL, Nguyen ST, Pham DT. Nocturnal high blood pressure and left ventricular hypertrophy in patients with chronic kidney disease. Biomed Res Ther. 2025, 12:7090-6. 10.15419\/bmrat.v12i1.953","journal-title":"Biomed Res Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/506093-masked-nocturnal-hypertension-and-hidden-organ-risk-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T13:46:37Z","timestamp":1782395197000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/506093-masked-nocturnal-hypertension-and-hidden-organ-risk-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":37,"URL":"https:\/\/doi.org\/10.7759\/cureus.111479","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,25]]}}}